Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Dr. Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Leeds Teaching Hospitals Trust, United Kingdom

Dr. Randeni A. Adithi H. Randeni is a Foundation Year One doctor at Leeds Teaching Hospital Trust with a dynamic portfolio in clinical research, innovation, and academic leadership. A graduate of the University of Leeds (MBChB), she has gained international exposure through observerships and research collaborations in the UK and USA, including SUNY Upstate. Her scholarly contributions span neurosurgery, cerebrospinal fluid dynamics, and biomedical innovation, with publications in top-tier journals such as IJMS, BJS, and BMC Medical Education. Dr. Randeni has received numerous awards and bursaries and is an active educator and mentor. Her leadership roles in university bodies and national societies reflect her commitment to academic excellence and inclusivity. With a future goal of specializing in neurosurgery, she aims to contribute to translational research and advance surgical practice globally through innovation and collaboration.

Profile

🎓 Education

Dr. Adithi Randeni earned her Bachelor of Medicine and Bachelor of Surgery (MBChB) from the University of Leeds, where she excelled in both academic and research endeavors. Her education was enriched by multiple research projects and electives across the UK and internationally, including SUNY Upstate Medical University in the USA. During her time at Leeds, she engaged deeply with translational research, contributing to projects on hydrocephalus, tissue engineering, neurotrauma, and breast cancer genetics. Her academic training included structured research programs and specialized modules in biomedical innovation, CSF dynamics, and advanced surgical techniques. She also undertook audits, systematic reviews, and service evaluations during clinical placements. Beyond formal education, she participated in national research fellowships and student interest groups that fostered interdisciplinary learning and mentorship. Dr. Randeni’s educational journey reflects a strong integration of clinical knowledge with scientific inquiry, preparing her for a future as a research-driven neurosurgeon and academic leader.

🧪 Experience

Dr. Adithi Randeni currently serves as a Foundation Year One doctor at Leeds Teaching Hospital Trust, where she is engaged in hands-on patient care, audits, and quality improvement projects. She has amassed extensive research experience through clinical, translational, and lab-based projects, including those at SUNY Upstate and the University of Leeds. Her past roles include conducting systematic reviews, performing service evaluations in neurosurgery, and leading national student surveys like SMART. She has presented her findings at both national and international conferences and has co-authored peer-reviewed articles and a book chapter. In addition to clinical duties, she has held leadership roles in student organizations, served as a medical student representative, and organized educational workshops. Her involvement with professional societies and interdisciplinary teams highlights her ability to balance clinical work, academic productivity, and collaborative initiatives, making her a well-rounded early-career professional with a clear trajectory in neurosurgical research and innovation.

🏅 Awards and Honors

Dr. Adithi Randeni has been the recipient of numerous academic awards, conference bursaries, and leadership recognitions during her medical training. Her achievements include international presentation opportunities and publication accolades for research on hydrocephalus, surgical outcomes, and student engagement in research pathways. She was invited to co-author a chapter in Springer’s “Arachnoid Cysts: State-of-the-Art” and has contributed to high-impact journals like the British Journal of Surgery and BMC Medical Education. She has earned research travel grants, elective placement scholarships, and teaching recognitions for organizing peer education workshops. Active in student leadership, she received commendations for her roles within the Medical Student Representative Council and societies such as NANSIG and the National MedTech Foundation. Her selection for the “Best Researcher Award” nomination reflects her growing influence in academic medicine. These honors affirm her commitment to excellence in research, innovation, and medical education at an early stage of her professional journey.

🔬 Research Focus

Dr. Adithi Randeni’s research focus lies at the intersection of neurosurgery, cerebrospinal fluid (CSF) dynamics, and biomedical innovation. She has explored pathological mechanisms such as abnormal transcytosis in hydrocephalus, authored a chapter on the genetics of arachnoid cysts, and is actively investigating CSF composition in hydrocephalus through collaborations with SUNY Upstate. Her research interests also include neurotrauma, surgical outcomes, antimicrobial stewardship, and tissue-engineered cardiovascular grafts. With a strong inclination toward translational research, she integrates clinical insights with lab-based findings to drive innovation. Dr. Randeni also explores medical education, having co-led the SMART study on student engagement in research. Her contributions aim to bridge the gap between bedside care and bench science, with ongoing work assessing surgical site infections and diagnostic accuracy in neurosurgical imaging. She is passionate about leveraging biomedical research and digital tools to enhance patient outcomes and surgical practice, particularly in underserved and complex neurological conditions.

Conclusion

Dr. Adithi Randeni exemplifies the fusion of clinical excellence, research innovation, and educational leadership, positioning her as a promising future leader in neurosurgery and translational science.

Publications
  • Abnormal Transcytosis Mechanisms in the Pathogenesis of Hydrocephalus: A Review

    International Journal of Molecular Sciences
    2025-05-19 | Journal article
    Part ofISSN: 1422-0067
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurthy
  • Genetics of Arachnoid Cysts

    Arachnoid Cysts
    2023 | Book chapter
    Part ofISBN: 9783031227004
    Part ofISBN: 9783031227011
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurth
  • Cross-sectional Survey of Medical student perceptions of And desires for Research and Training pathways (SMART): an analysis of prospective cohort study of UK medical students

    BMC Medical Education
    2023-12-15 | Journal article
    Part of ISSN: 1472-6920
    CONTRIBUTORS: Gokul Parameswaran; Amelia Bowman; Catherine Swales; Setthasorn Zhi Yang Ooi; Shie Wei Chan; Priya Rose Babu; Daniele Ramsay; Sofia Kostoudi; Soham Bandyopadhyay; SMART-NANSIG-InCiSion Collaborative et al.

Marta Comes Carsí | Psychiatry and ophthalmology | Women Researcher Award

Mrs. Marta Comes Carsí | Psychiatry and ophthalmology | Women Researcher Award

Hospital Clínico Universitario de Valencia, Spain

Mrs. Marta Comes Carsí is a Spanish ophthalmologist from Valencia with extensive clinical and academic expertise in visual sciences, retina, and ocular pathologies. Born on November 12, 1992, she currently serves as a Facultativo Especialista in Ophthalmology at the Hospital Clínico Universitario de Valencia. Her medical career is marked by specialized training across top hospitals in Spain, including Barcelona and Valencia, and advanced postgraduate studies in retina, uveitis, and clinical ophthalmology. With multiple master’s degrees and international certifications from the European Board of Ophthalmology and the International Council of Ophthalmology, Mrs. Comes Carsí combines a strong academic foundation with practical excellence. Her research explores structural and functional alterations of the retina, especially in psychiatric conditions, and has been published in prestigious ophthalmological journals. Fluent in English and Catalan, she actively contributes to continuing medical education and integrates evidence-based practices in clinical care.

Profile

🎓 Education

Mrs. Marta Comes Carsí obtained her medical degree from the Universitat de València in 2016, laying a strong foundation for her specialization in ophthalmology. She then completed a Master’s in Clinical Medicine at Universidad Camilo José Cela (2017), followed by multiple postgraduate degrees at Universidad Tecnológica de las Islas Canarias in Retina and Uveitis, Clinical Ophthalmology, and Ocular Pathologies (2024). She earned the European Board of Ophthalmology Diploma (EBO) and multiple certifications from the International Council of Ophthalmology (ICO) in Clinical Ophthalmology, Visual Sciences, and Optics. Her extensive additional training includes accredited university courses in surgical techniques, pediatric glaucoma, corneal diseases, and ocular inflammation. This multidisciplinary academic background equips her with the knowledge to manage complex ocular conditions and to contribute significantly to academic research and clinical teaching. Her education reflects a continuous commitment to staying updated with evolving practices and innovations in visual science and eye health.

🧪 Experience

Mrs. Marta Comes Carsí has accumulated a wide range of clinical experience through her progressive roles in leading Spanish medical institutions. She began her residency at Hospital Clínico y Provincial de Barcelona in 2017 and continued at the Hospital Clínico Universitario de Valencia from 2020 to 2024. Her dedication and expertise earned her a permanent position as a Facultativo Especialista in Ophthalmology at the same Valencia hospital, where she now works part-time. Mrs. Comes Carsí’s clinical work spans general ophthalmology, retinal pathologies, anterior segment imaging, and pediatric ocular disorders. Her experience also includes performing ophthalmologic surgeries and diagnosing complex visual system disorders. She actively participates in scientific and academic programs, blending patient care with educational involvement. Her clinical background, enriched with hands-on training and high-level certifications, reflects a comprehensive and evolving practice in visual health, making her a reliable clinician, researcher, and educator in the field of ophthalmology.

🏅 Awards and Honors

Mrs. Marta Comes Carsí’s commitment to academic and clinical excellence has been recognized through several prestigious achievements. She was awarded the European Board of Ophthalmology (EBO) Diploma in 2024, a significant credential demonstrating her advanced expertise across European standards. Additionally, she earned certifications from the International Council of Ophthalmology in Clinical Ophthalmology, Visual Sciences, and Optics—honors that underscore her global standing in ophthalmic education. Her dedication to continuing education is evident in her completion of specialized university-accredited courses in glaucoma, surgical ophthalmology, corneal diseases, and pediatric pathologies. These honors signify her commitment to lifelong learning and delivering the highest standards of care in ophthalmology. Her active involvement in continuing education programs and international evaluations confirms her drive for excellence and positions her as a highly respected ophthalmologist committed to best practices, academic advancement, and patient-centered care.

🔬 Research Focus

Mrs. Marta Comes Carsí’s research primarily focuses on the intersection of ophthalmology and systemic or neuropsychiatric conditions, particularly studying structural and functional retinal changes. Her recent work includes investigations into visual function and retinal morphology in patients with bipolar disorder, indicating a multidisciplinary approach that integrates psychiatry and ophthalmology. She also contributes to anterior segment imaging studies, such as iris abnormalities using optical coherence tomography (OCT). Her publications, appearing in Archivos de la Sociedad Española de Oftalmología, highlight her emphasis on evidence-based clinical advancements. Mrs. Comes Carsí applies her research findings to refine diagnostic accuracy and therapeutic approaches in complex ocular pathologies. Her focus on retinal diagnostics and systemic ocular manifestations supports the advancement of personalized ophthalmic care. By combining advanced imaging, clinical insight, and inter-disciplinary research, she is contributing to a broader understanding of ocular biomarkers relevant to both ophthalmology and systemic disease diagnosis.

Conclusion

Mrs. Marta Comes Carsí exemplifies the integration of clinical expertise, academic rigor, and research innovation in modern ophthalmology. With a solid educational foundation, diverse hospital experience, and internationally recognized certifications, she advances patient care while contributing to scientific understanding of ocular diseases. Her work stands at the forefront of visual science and clinical excellence.

Publications
  • Marta Comes Carsí; Delia Hernández Pérez; Antonio Miguel Duch Samper. Subretinal hemorrhages
    with subfoveal involvement after blunt ocular trauma, in a patient with pseudoxanthoma elasticum and
    angioid streaks. Archivos de la Sociedad Española de Oftalmología (English Edition). 99 – 9, pp. 412.
    Elsevier BV, 22/06/2024. DOI: 10.1016/j.oftale.2024.05.013. Epub 2024 Jun 22.>. ISSN 2173-5794

  • Marta Comes Carsí; Noemí Ruiz Del Río; Antonio Miguel Duch Samper. Myopic macular pit with
    scleral dehiscence in highly myopic patient. Archivos de la Sociedad Española de Oftalmología
    (English Edition). Elsevier BV, 20/07/2024. DOI: 10.1016/j.oftale.2024.07.008>. ISSN 2173-5794
  • Marta Comes Carsí; Elena Gracia Rovira; Laura Manfreda Domínguez; Vicente Tomás Pérez
    Torregrosa; John Paul Liscombe Sepúlveda; Antonio Miguel Duch Samper. Oclusión combinada de
    vena central de la retina y arteria ciliorretiniana en dos pacientes jóvenes. Archivos de la Sociedad
    Espanola de Oftalmologia. Elsevier BV, 19/08/2024. https://doi.org/10.1016/j.oftal.2024.08.006.>.
    ISSN 0365-6691
  • Noemí Ruiz Del Río; Marta Comes Carsí; Leyre Sanz Gallen. Roséola sifilítica iridiana. Utilidad de la
    tomografía de coherencia óptica de segmento anterior. Archivos de la Sociedad Espanola de
    Oftalmologia. Elsevier BV, 24/08/2024. https://doi.org/10.1016/j.oftal.2024.08.004>. ISSN 0365-6691
  • Marta Comes Carsi; José Miguel Vilaplana Mora; Laura Manfreda Domínguez; Carlos Cañete
    Nicolás; Antonio Miguel Duch Samper. Alteraciones en la función visual y en la estructura retiniana
    de los pacientes con trastorno bipolar. Archivos de la sociedad española de oftalmología. (España):
    elsevier, 05/2025. <https://doi.org/10.1016/j.oftal.2025.03.007>.
  • Marta Comes Carsí; Sergio Alfredo Maugard Tepper; Antonio Miguel Duch Samper. Mamilaciones
    de iris bilaterales. Imagen de tomografía de coherencia óptica del segmento anterior.ARCHIVOS DE
    LA sociedad española de oftalmología. 04/2025.<https://doi.org/10.1016/j.oftal.2024.11.005>.
  • Marta Comes Carsí; Sergio Alfredo MAUGARD TEPPER; Amparo Lanuza García; Antonio Miguel
    Duch Samper. Orbital abscess surgery in a patient with odontogenic pansinusitis. Acta
    ophthalmologica. 100 – S275, pp. 1755 -3768. John Wiley & Sons, 20/12/2022.
    https://doi.org/10.1111/j.1755-3768.2022.0267>. ISSN 1755-375X

 

Forshing Lui | Neurology | Best Researcher Award

Prof. Forshing Lui | Neurology | Best Researcher Award

Dr. For-Shing Lui, a U.S. citizen and licensed neurologist in California, the UK, and Hong Kong, is an esteemed academic and clinician with over four decades of international experience in neurology and internal medicine, currently serving as Professor of Neurology at California Northstate University College of Medicine (CNUCOM), where he contributes significantly to medical education, curriculum development, and professional regulatory boards.

Profile

Education 🎓

Dr. Lui completed his M.B.B.S. from the University of Hong Kong in 1978, followed by an internal medicine residency (1978–1982) at the same institution; he then undertook neurology fellowship training at Newcastle General Hospital, UK (1982–1984), and a neurology residency at UC Davis (1995–1999), also serving as Chief Resident; his qualifications include being a Diplomate of the American Board of Psychiatry and Neurology, Fellow of the Royal College of Physicians (Edinburgh), Fellow of the Hong Kong Academy of Medicine, and Fellow of the American Academy of Neurology.

Experience 👨‍🏫

Dr. Lui has served as Expert Consultant and Reviewer for the Medical Board of California, Professor and Course Director at CNUCOM since 2014, Chair of Clinical Sciences, and Vice Chair of Education; formerly, he was Staff Neurologist and Chief of Neurology at Kaiser Permanente, Clinical Professor at UC Davis, and practiced as a neurologist and internist in Hong Kong; his roles spanned clinical practice, academic leadership, curriculum design, quality assurance, and international consultancy.

Awards & Recognitions 🏅

Dr. Lui received the 2022 A.B. Baker Teacher Recognition Award from the American Academy of Neurology, the ITLE University Distinguished Teacher Award in 2021, and multiple CNUCOM Professor of the Year Awards (2019–2023); his national recognitions include listings in America’s Top Physicians and Sacramento Magazine’s Top Doctors; he won the Croucher Fellowship (1982), John Anderson Gold Medal (1978), and several medical school scholarships for academic excellence, including the Li Shu Fan Prize in Pharmacology.

Research Interests 🔬

Dr. Lui’s academic and clinical interests lie in neurology education, vascular neurology, neuroimaging, and multiple sclerosis, with a deep commitment to medical pedagogy and curriculum leadership; his research integrates neurodiagnostic techniques with clinical neurology, particularly in imaging-based teaching, and he has presented regularly at neuroradiology conferences and contributed to educational innovation in neurology training at both Kaiser Permanente and CNUCOM, reflecting a lifelong dedication to mentoring, patient care, and advancing neurologic knowledge.

Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

Dr. Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

El Dr. Lucas Muñoz-López 🎓 es logopeda neurológico especializado en rehabilitación logopédica en daño neurológico 🧠, con amplia experiencia clínica y académica 👨‍🏫. Tras graduarse en Logopedia por la Universidad de Granada en 2015, combinó práctica profesional y formación de posgrado, incluyendo dos másteres y un doctorado con mención Cum Laude 🏅. Ha ejercido como docente universitario en Melilla y Ceuta, y colabora en investigación con publicaciones en revistas como Frontiers in Psychology 📖. Además, ha tutorizado numerosos TFG y TFM 🎓. Su trabajo integra logopedia clínica, investigación sobre alteraciones de la comunicación y neurociencias, aportando al avance académico y a la rehabilitación de pacientes. Es autor de un libro publicado y miembro activo en proyectos de evaluación y tratamiento en contextos educativos y sanitarios 🏥. Su pasión por la docencia y la terapia lo posiciona como referente en logopedia clínica e investigación 📈.

Profile

Education 🎓

Dr. Muñoz-López 🧠 inició su carrera académica con el Grado en Logopedia (2015) en la Universidad de Granada 🎓, complementándolo ese mismo año con un Máster en Logopedia Clínica en Daño Cerebral (Isep Clinic, Madrid) 💡. En 2017 completó su segundo máster en Neurociencias Básicas y Aplicadas y Dolor en la Facultad de Medicina de Granada 🔬. Culminó su formación con un Doctorado en Psicología y Logopedia en la Universidad de Granada (2021) con mención Cum Laude 🏅, convirtiéndose en experto en alteraciones de la comunicación y rehabilitación neurológica 🧬. Su formación académica combina sólidos conocimientos clínicos, teóricos y metodológicos para abordar con éxito la intervención logopédica y la investigación científica 🏛️. Además, su trabajo refleja una constante actualización y compromiso con la excelencia educativa y terapéutica 💯.

Experience 👨‍🏫

Desde 2015, el Dr. Muñoz-López 🩺 ha desarrollado una sólida trayectoria profesional como logopeda clínico, combinando práctica asistencial con docencia universitaria 👨‍🏫. Ha ejercido en el Centro de Valoración y Orientación de Granada como Auxiliar Técnico en Logopedia 🏥, además de impartir clases en los campus de Ceuta y Melilla de la Universidad de Granada 📚. Ha sido tutor de TFG y TFM en varias universidades, incluyendo la Universidad de Granada y la Universidad Internacional de La Rioja ✍️. Su experiencia docente abarca asignaturas de logopedia, neuropsicología y psicopedagogía en grados y másteres universitarios 🎓. Además, colabora activamente en proyectos de intervención educativa, rehabilitación y formación de futuros profesionales. Su enfoque multidisciplinar y experiencia en contextos clínicos y penitenciarios 🏛️ le permiten aplicar soluciones eficaces e innovadoras en su área.

Awards & Recognitions 🏅

Dr. Muñoz-López ha recibido mención Cum Laude 🎖️ por su tesis doctoral en Psicología y Logopedia en la Universidad de Granada (2021) 🏅. Su tesis fue publicada como libro 📗, reafirmando su valor académico. Ha logrado publicar en la revista Frontiers in Psychology (Q2, JCR 2.99) 🧠, destacándose en el área de psicología y neurociencias. También ha publicado en la revista Journal for Educators, Teachers and Trainers, indexada en bases relevantes como Scopus y Dialnet 📖. Su libro fue editado por la Editorial Académica Española, con índice ICEE de 0.299 📘. Estos reconocimientos consolidan su reputación científica, reflejando la calidad y relevancia de su producción académica, así como su compromiso con la excelencia investigadora y docente 🧑‍🔬✨.

Research Interests 🔬

El Dr. Muñoz-López centra su investigación en la rehabilitación logopédica de alteraciones de la comunicación 🗣️, disfagia 🥄 y terapia miofuncional 💪, con especial atención a contextos neurológicos y penitenciarios 🏛️. Su trabajo profundiza en la intersección entre neurociencias, psicología y logopedia 🧠, explorando tanto enfoques clínicos como educativos. Ha contribuido al avance del conocimiento en alteraciones del lenguaje, evaluación cognitiva y técnicas de intervención para pacientes con daño cerebral adquirido 🧬. Además, participa en estudios sobre integración social, intervención educativa en contextos de riesgo y psicología forense ⚖️. Su enfoque combina metodología cuantitativa, intervención basada en evidencia y aplicación clínica, orientado siempre a mejorar la calidad de vida de las personas con trastornos de la comunicación 💬💡.

Publications
  • Validation and Spanish Adaptation of the Resilience Scale ER-23 in a University Population

    Healthcare
    2025-04-12 | Journal article
    CONTRIBUTORS: Isabel Ramírez-Uclés; Julia Otero; F. Pablo Holgado-Tello; Lucas Muñoz-López; María B. Sánchez-Barrer
  • Analysis of writing in personality disorders in prison population

    Frontiers in Psychiatry
    2024 | Journal article
    EID:
    Part ofISSN: 16640640
    CONTRIBUTORS: Muñoz-López, L.; Fernández-García-Valdecasas, B.; López-Rodríguez, S.; Sánchez-Barrera, M.B.
  • Transformation of Higher Education: Discussion of the Dimensions, Trends and Scenarios of Change in Ibero-America

    Education Sciences
    2024 | Journal article
    Part ofISSN: 22277102
    CONTRIBUTORS: Fernández Cruz, M.; Fernández García Valdecasas, B.; Muñoz López, L.; López Rodríguez, S
  • Associations of Reversal Learning Performance With Personality Disorder Profile and Drug Abuse History in a Sample of Prison Inmates

    2024-09-18 | Journal article
    CONTRIBUTORS: Raquel Martín-Ríos; José C. Perales; Francisca López-Torrecillas; Lucas Muñoz Lóp

Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Dr. Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Dr. Vahid Rashedi 👨‍⚕️, an esteemed Assistant Professor of Gerontology at the University of Social Welfare and Rehabilitation Sciences 🇮🇷, has made outstanding global contributions in aging, cognition, and psychogeriatrics 🌍🧠. With a Ph.D. in Gerontology (2017) 🎓 and extensive editorial duties across high-impact journals 📚, he’s actively involved as a Senior Collaborator with the Global Burden of Disease Project at IHME, University of Washington 🇺🇸. Recognized as a Top 1% scientist by Stanford University in 2024 🏅, he combines academic excellence, innovation, and impactful research. His interdisciplinary work spans gerontology, rehabilitation, mental health, and cognitive science, cementing his status as a global leader in aging research 🌐💡.

Profile

Education 🎓

Dr. Rashedi began his academic path with a Bachelor’s and Master’s degree in Rehabilitation Sciences 🎓🦾, focusing on geriatric care and assistive technology. He earned his Ph.D. in Gerontology with distinction in 2017 🥇, building expertise in psychogeriatrics, mental health, and cognitive decline. His academic training was rooted in interdisciplinary frameworks linking medicine, psychology, and social work 🔬💬. This diverse education empowered him to bridge clinical insights with research, enabling innovative health solutions for elderly populations 👵👴. He complements formal education with global scientific memberships and ongoing collaborations with prestigious institutes, such as IHME 🌎, emphasizing lifelong learning and cutting-edge research.

Experience 👨‍🏫

Dr. Rashedi has over a decade of rich academic and research experience, currently serving as Assistant Professor at the University of Social Welfare and Rehabilitation Sciences 🏫. Since 2019, he has been a Senior Collaborator at IHME, University of Washington, contributing to the Global Burden of Disease project 📊🌐. He has authored 126 indexed journal articles 📑, published a book 📖, and holds four patents, including rehabilitation innovations like the vibrating ankle-foot orthosis 🦿. He is a prolific editorial board member and associate editor for over 10 international journals 📘🖋️. His work in psychogeriatrics and cognition has garnered global recognition, highlighting his leadership and mentoring roles 👨‍🏫🏅.

Awards & Recognitions 🏅

Dr. Rashedi is recognized globally for his scientific excellence, notably ranked in the Top 1% of scientists worldwide by Stanford University in 2024 🌟📈. He holds editorial roles in Frontiers, CGJ, and the Journal of Gerontology, reflecting scholarly esteem 📚. He is a trusted reviewer for numerous high-impact journals and was honored with national and international awards 🥇. His patented inventions in geriatric rehabilitation demonstrate a blend of innovation and clinical value 💡🏥. His GSA, APA, and ISTAART memberships validate his international standing 👏🌐. These honors underscore his unwavering dedication to improving elderly lives through evidence-based science and collaboration 🤝

Research Interests 🔬

Dr. Rashedi’s research delves into psychogeriatrics, mental health, and cognitive disorders in aging populations 🧠👴. As part of the Global Burden of Disease team at IHME 🌍, he contributes to global health analytics, shaping international aging policies 📊. His innovations include assistive devices with therapeutic functions, bridging technology and clinical rehabilitation 🛠️⚙️. With 63 research projects and over 26,000 citations 🔍📈, his scholarly output is extensive and impactful. He leads investigations on dementia, geriatric depression, and cognitive resilience, supported by his roles in editorial boards and scientific societies 🧬📘. His mission is to translate research into real-world health solutions for aging communities 🌟🩺.

Publications 

Karin N Westlund | Chronic Pain Relief | Best Researcher Award

Dr. Karin N Westlund | Chronic Pain Relief | Best Researcher Award

Dr. Karin N. Westlund High is a distinguished neuroscientist and physiologist, currently a Distinguished Professor at UNM School of Medicine and a Research Physiologist at NM VA Health Care. 🇺🇸 She is recognized for her groundbreaking work in pain mechanisms and translational neurobiology. 📚 Her leadership as Vice Chair for Research and longstanding academic contributions span over four decades, advancing the fields of anesthesiology, neuroscience, and chronic pain treatment. 🧠💉

Profile

Education 🎓

Dr. Westlund High earned a B.A. (Zoology) 🎓 from the University of Texas at Austin (1975), followed by an M.A. in Zoology (1976). She received her Ph.D. in Physiology & Biophysics from UTMB Galveston in 1981. 🧪 During her graduate and postdoctoral years, she developed strong expertise in pain pathways and biophysics. 🧬 Her education laid a solid foundation for her influential career in academic medicine and neuroscience research. 📖🧠

Experience 👨‍🏫

From 1982 to the present, Dr. Westlund High has held key roles: tenured professor at UTMB Galveston, University of Kentucky, and UNM. 🏫 She was also Vice Chair for Research at UNM Anesthesiology (2017–2024) and served in VA medical systems in KY & NM. 🏥🧪 She led cell biology graduate programs, taught extensively in medicine and dentistry, and contributed to national research ethics. 🧑‍🏫🧠

Awards & Recognitions 🏅

Dr. Westlund High is the recipient of over 20 prestigious honors, including the Frederick W.L. Kerr Award (2008) 🏆, Innovator of the Year (2023), and multiple NIH awards. 💡 She’s been honored for teaching, research excellence, and innovation, including winning EQUALIZE Pitch Competition and a U.S. patent award (2025). 🇺🇸 She has served on editorial boards and grant panels globally, shaping pain research. 🌍🔬

Research Interests 🔬

Her research centers on pain neurobiology 🔍—investigating trigeminal nerve injury, chronic pain, neuroinflammation, and targeted therapeutic antibodies. 🧠💊 With deep NIH and VA support, she has led studies using translational animal models to discover novel pain relief methods. 🐭⚗️ Her work impacts both clinical and preclinical pain management, with over 40 years of translational insights and innovation. 💥📈

Publications 
  • Role of HDAC5 Epigenetics in Chronic Craniofacial Neuropathic Pain

    International Journal of Molecular Sciences
    2024-06 | Journal article | Author
    CONTRIBUTORS: Sifong Elise Hui; Karin N Westlund
  • Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception

    International Journal of Molecular Sciences
    2023-08 | Journal article | Author
    CONTRIBUTORS: Terry A. McNearney; Karin N Westlund
  • Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain

    International Journal of Molecular Sciences
    2023-07 | Journal article | Author
    CONTRIBUTORS: Adinarayana Kunamneni; Marena A. Montera; Ravi Durvasula; Dr Sascha Alles; Sachin Goyal; Karin N Westlund

Jolanta Dorszewska | Neurobiology | Women Researcher Award

Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award

Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland 🧠🇵🇱. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases 🧬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimer’s and Parkinson’s disease 🧪. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters 📚. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies 🌍.

Profile

Education 🎓

Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 🏅. She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 🧪. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 🎓. Her academic growth includes training in medical genetics from 2012 to 2020 🧬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence 💡.

Experience 👨‍🏫

Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS 👩‍🔬. She was a Research Scientist in New York (1999–2000) 🗽 and has led the Laboratory of Neurobiology since 2004 🧠. She became Full Professor in 2022 🏛️. She also lectured at the National High Medical School in Pila (2012–2018) 📖. Her career blends hands-on research, global collaboration, and dedicated academic leadership 📚. She continues to mentor, publish, and drive innovations in neurology and neurochemistry 🚀

Awards & Recognitions 🏅

Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) 🌐. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research 📘. A section and associate editor for journals across the USA, UK, and Poland 🌍, she’s a key figure in scientific publishing 🖋️. She’s affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books 📚.

Research Interests 🔬

Research Focus:
Her research spans lipid metabolism in hypoxia 🧫, cerebral sterols 🧠, neurotransmitters (serotonin, dopamine) 🧪, apoptosis in aging and disease (Alzheimer’s, Parkinson’s) 💔, and gene polymorphisms (MTHFR, MAO-B, PARK) 🧬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration 🧠. Since 2009, she’s focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics ⚙️. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry 🔍. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases 🚀.

Publications 
  • Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson’s disease

    IBRO Neuroscience Reports
    2025-06 | Journal article
    CONTRIBUTORS: Jolanta Dorszewska; Jolanta Florczak-Wyspiańska; Bartosz Słowikowski; Wojciech Owecki; Oliwia Szymanowicz; Ulyana Goutor; Mateusz Dezor; Paweł P. Jagodziński; Wojciech Kozubski
  • Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

    Sclerosis
    2025-04-03 | Journal article
    CONTRIBUTORS: Katarzyna Wiszniewska; Małgorzata Wilk; Małgorzata Wiszniewska; Joanna Poszwa; Oliwia Szymanowicz; Wojciech Kozubski; Jolanta Dorszewsk
  • Unraveling the Role of Proteinopathies in Parasitic Infections

    Biomedicines
    2025-03-03 | Journal article
    CONTRIBUTORS: Mikołaj Hurła; Damian Pikor; Natalia Banaszek-Hurła; Alicja Drelichowska; Jolanta Dorszewska; Wojciech Kozubski; Elżbieta Kacprzak; Małgorzata Paul
  • Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine

    International Journal of Molecular Sciences
    2025-02-14 | Journal article
    CONTRIBUTORS: Małgorzata Anna Lewandowska; Agata Różycka; Teresa Grzelak; Bartosz Kempisty; Paweł Piotr Jagodziński; Margarita Lianeri; Jolanta Dorszewska

Tran Chau My Thanh | Neuroscience | Young Scientist Award

Dr. Tran Chau My Thanh | Neuroscience | Young Scientist Award

Dr. Tran Chau My Thanh, a dedicated researcher at Duy Tan University, Vietnam 🇻🇳, holds a medical degree and Ph.D. from Hue University of Medicine and Pharmacy 🎓. Her work bridges the gap between clinical medicine and molecular biology 🧬. With a strong passion for translational research, she focuses on using bioinformatics and genomic tools for early diagnosis and targeted therapy development for diseases like cancer, diabetes, and cardiovascular disorders 💉. Through CRISPR/Cas9 and RNA networks, she aims to revolutionize patient-specific treatment pathways 🚀. Her extensive lab experience, scholarly publications, and ongoing innovations make her a promising leader in biomedical science 🏅.

Profile

Education 🎓

Dr. Thanh earned her Medical Degree (M.D.) from Hue University of Medicine and Pharmacy 🏥 and went on to complete her Doctorate (Ph.D.) in the same prestigious institution 🎓. Her education was deeply rooted in both clinical and research training, equipping her with a comprehensive understanding of human health and disease 🧠. Throughout her academic journey, she focused on genomics, molecular medicine, and biotechnology 🔬. The rigorous curriculum and hands-on exposure in advanced labs trained her in modern diagnostic tools and therapeutic innovations ⚙️. She also mastered computational biology and molecular interactions, forming a solid foundation for her groundbreaking work in RNA regulation and gene editing technologies such as CRISPR/Cas9 🧪.

Experience 👨‍🏫

Dr. Thanh brings rich experience as a medical doctor and academic at Duy Tan University 🏫. Her research career spans multiple roles in molecular diagnostics, bioinformatics, and therapeutic innovation 🧬. She has led studies on disease biomarkers, participated in international collaborations 🌐, and worked extensively with cell lines, recombinant DNA, and next-gen sequencing data 🔍. Her proficiency in wet lab and dry lab environments empowers her to integrate experimental biology with computational modeling 🧫💻. Alongside mentoring students and publishing SCI-indexed research, she contributes to translational medicine by connecting bench science to bedside applications, helping advance precision medicine for critical illnesses 💡.

Awards & Recognitions 🏅

Dr. Thanh is a nominee for the Young Scientist Award by the International Cognitive Scientist Awards 🧠🏆. Her impactful work on circular RNAs, miRNAs, and disease biomarker networks has garnered international recognition 🌍. She’s been acknowledged in high-impact journals for discoveries related to coronary heart disease and cancer diagnostics 📖. Her scholarly articles are indexed in SCI and Scopus, and she continues to influence the biomedical community through conference presentations, peer reviews, and academic collaborations 🤝. As a rising figure in molecular biology, her research promises transformative outcomes for early disease detection and targeted therapies 🧬✨.

Research Interests 🔬

Dr. Thanh’s research explores circRNA/miRNA/mRNA interactions, protein-protein networks, and gene function analysis 🧬🧠. She is driven by the quest to discover novel biomarkers for early diagnosis of complex diseases such as cancer, stroke, and diabetes 💊. Her focus includes CRISPR/Cas9 gene editing, molecular docking, and simulations for drug discovery and target validation 💻🧪. She also builds interaction networks to map LncRNA/CircRNA/miRNA/gene/protein-drug relationships, contributing to personalized medicine approaches 🎯. Through bioinformatics, she decodes gene expression dynamics and immune infiltrations to enable efficient diagnostics and therapeutics 💡. Her ultimate goal is to bridge computational biology with translational research for global health improvement 🌐💚.

Publications 

1. Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression
by sponging miRNA-338-3p via regulating the expression of ETS1
2. Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as
potential biomarker for coronary heart disease
3. Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of
bioinformatics data

Yuanyuan Li | Movement Disorder | Best Researcher Award

Dr. Yuanyuan Li | Movement Disorder | Best Researcher Award

🧠 Dr. Yuanyuan Li is a dedicated neurologist and researcher specializing in neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. She obtained her Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine and has been actively involved in cutting-edge research at Ruijin Hospital’s Department of Neurology. As a project leader, she has explored the role of α-synuclein in dopaminergic neurons, investigating its transport pathways and impact on cell viability. Dr. Li has authored multiple high-impact publications in renowned journals such as Neurology and J Neuroinflammation. Her work has contributed significantly to understanding the early biomarkers of neurodegenerative disorders. She has received prestigious awards, including the National Scholarship for Doctoral Students and the Outstanding Graduate Award from Shanghai Jiao Tong University. With numerous conference presentations and accolades, Dr. Li continues to drive forward advancements in neurodegenerative disease research. ✨📚

Profile

Education 🎓

🎓 Dr. Yuanyuan Li completed her Ph.D. in Neurology at Shanghai Jiao Tong University School of Medicine, where she focused on neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. Her doctoral research emphasized the role of α-synuclein in dopaminergic neurons, uncovering its impact on neurodegeneration. Throughout her academic journey, Dr. Li consistently demonstrated excellence, earning the First-Class Academic Scholarship and the Meritorious Student Award. She was recognized as an Outstanding Graduate and received the prestigious National Scholarship for Doctoral Students. Beyond coursework, she actively engaged in translational research, bridging laboratory findings with clinical applications. Her education has provided a strong foundation in neurobiology, molecular neuroscience, and clinical neurology. With a passion for uncovering early biomarkers of neurodegeneration, Dr. Li’s educational background has shaped her into a leading researcher in the field. 📖🧬

Experience 👨‍🏫

Dr. Yuanyuan Li has extensive research experience at Ruijin Hospital’s Department of Neurology, affiliated with Shanghai Jiao Tong University School of Medicine. As a principal investigator, she led the Shanghai Jiao Tong University Doctoral Innovation Fund project, studying α-synuclein’s transport mechanisms in dopaminergic neurons and its effects on cell viability. Her expertise spans biomarker discovery, neuroinflammation, and disease progression in neurodegenerative disorders. She has collaborated on numerous high-impact studies published in Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease. Dr. Li has also presented her findings at major conferences, including the National Neurology Conference and the Oriental Neurology Conference. Her experience in both basic and clinical research allows her to bridge the gap between laboratory discoveries and patient applications, advancing diagnostic and therapeutic strategies for Parkinson’s disease and related disorders. 🏥🧠

Awards & Recognitions 🏅

Dr. Yuanyuan Li has received numerous prestigious awards for her contributions to neurology and neuroscience research. She was awarded the National Scholarship for Doctoral Students, recognizing her academic excellence and groundbreaking research. She also received the Outstanding Graduate Award and the Meritorious Student Award from Shanghai Jiao Tong University. Her outstanding academic performance earned her the First-Class Academic Scholarship, demonstrating her dedication to advancing neurological research. Dr. Li has been recognized for her contributions at major conferences, winning the “Excellent Paper Presentation” award at the Oriental Neurology Conference. Additionally, she secured First Prize for Poster Presentation at the “Bo Ji Yi Yuan” Academic Forum. Her accolades reflect her commitment to advancing our understanding of neurodegenerative diseases, particularly Parkinson’s disease. These honors highlight her as a rising star in the field of neurology. 🏅📜

Research Interests 🔬

🧪 Dr. Yuanyuan Li’s research focuses on neurodegenerative diseases, with an emphasis on Parkinson’s disease, REM sleep behavior disorder (RBD), and α-synuclein pathology. Her work explores the molecular mechanisms driving these disorders, particularly the role of α-synuclein in dopaminergic neurons, its transport pathways, and its impact on cell viability. She has also investigated immune biomarkers, neuroinflammation, and genetic variants associated with Parkinson’s progression. Dr. Li’s studies have contributed to identifying predictive markers for early-stage neurodegenerative diseases, aiding in early diagnosis and potential therapeutic interventions. Through her publications in top journals like Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease, she has advanced knowledge in the field. Her work integrates clinical and experimental neuroscience, bridging gaps between laboratory findings and real-world applications. Dr. Li’s research continues to shape the understanding of neurodegenerative disorders and their early detection. 🧬🔍

 

4Publications 
  • Gene Polymorphisms of Parkinson’s Disease Risk Locus and Idiopathic REM Sleep Behavior Disorder

    Biomedicines
    2025-03-24 | Journal article
    CONTRIBUTORS: Min Zhong; Yang Jiao; Aonan Zhao; Mengyue Niu; Jinjun Ran; Jun Liu; Yuanyuan Li
  • Understanding Causal Relationships Between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    Biomedicines
    2025-03-18 | Journal article
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.
  • Understanding Causal Relationships between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    2025-02-05 | Preprint
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.
  • Network disruption based on multi-modal EEG-MRI in α-synucleinopathies

    Frontiers in Neurology
    2024 | Journal article
    CONTRIBUTORS: Wang, Chunyi; Hu, Jiajia; Li, Puyu; Zhang, Ming; Zhou, Liche; Luo, Ningdi; Zhu, Xue; Yin, Qianyi; Zhong, Min; Zhou, Xinyi et al.

PİNAR ERKEKOGLU | Neurotoxicology | Best Researcher Award

Prof. PİNAR ERKEKOGLU | Neurotoxicology | Best Researcher Award

Prof. Dr. Pınar Erkekoğlu is a distinguished academician and toxicologist at Hacettepe University, serving as Head of the Department of Pharmaceutical Toxicology and Department of Vaccine Technology. She holds a PhD in toxicology (2009) and became a European Registered Toxicologist (ERT) in 2014. She conducted research at Joseph Fourier University, CEA/INAC/LAN, and completed her postdoctoral studies at MIT (2011-2013). With over 200 scientific publications, 10 edited books, and 15 book chapters, her work spans toxicology, neurotoxicology, and vaccinology. Her h-index is 34, with 107 SCI-indexed papers and numerous collaborations.

Profile

Education 🎓

Prof. Erkekoğlu earned her Pharmacy degree from Hacettepe University and a PhD in toxicology (2009). She gained international research experience at Joseph Fourier University and CEA/INAC/LAN during her doctorate. In 2011-2013, she pursued postdoctoral research at MIT, specializing in toxicology and environmental sciences. Recognized for her expertise, she became a European Registered Toxicologist (ERT) in 2014.

Experience 👨‍🏫

Prof. Erkekoğlu has extensive experience in toxicology, environmental sciences, and vaccinology. She is the Head of Pharmaceutical Toxicology and Vaccine Technology at Hacettepe University. She has worked at MIT, Joseph Fourier University, and CEA/INAC/LAN. With 49 research projects, 4 industry consultancies, and 12 collaborations, she has contributed significantly to toxicological sciences.

Awards & Recognitions 🏅

Prof. Erkekoğlu has received numerous awards, including Best Researcher and Women Researcher Awards. She is recognized internationally for her contributions to toxicology, neurotoxicology, and vaccine technology. She has served as an editor for scientific books, peer-reviewed journals, and major toxicology conferences.

Research Interests 🔬

Her research encompasses neurotoxicology, endocrine disruption, environmental toxicology, and vaccinology. She has published 107 SCI-indexed papers and 161 documents in Scopus across pharmacology, medicine, and environmental sciences. Her work explores the toxic effects of chemicals on human health and vaccine development.

Publications 

  • Prepubertal phthalate exposure can cause histopathological alterations, DNA methylation and histone acetylation changes in rat brain

    Toxicology and Industrial Health
    2025-03 | Journal article
    CONTRIBUTORS: Seyda Koc; Ekin Erdogmus; Ozlem Bozdemir; Deniz Ozkan-Vardar; Unzile Yaman; Pınar
    Erkekoglu; Naciye Dilara Zeybek; Belma Kocer-Gumusel
  • The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies

    Journal of Applied Toxicology
    2025-02 | Journal article
    CONTRIBUTORS: Sonia Sanajou; Anil Yirün; Göksun Demirel; Pinar Erkekoğlu; Gönül Şahin; Terken Baydar
  • Unveiling connections: bisphenol A and vitamin D dynamics in breast milk among healthy lactating mothers

    International Journal of Environmental Health Research
    2024-10-10 | Journal article
    CONTRIBUTORS: Esra Cinkilli Aktağ; Sıddika Songül Yalçin; Anıl Yіrün; Aylin Balci Özyurt; Pınar Erkekoğlu
  • Bisphenol derivatives in cord blood and association between thyroid hormones and potential exposure sources

    International Journal of Environmental Health Research
    2024-08-02 | Journal article
    CONTRIBUTORS: Merve Buke Sahin; Murat Cagan; Anıl Yirun; Aylin Balcı Ozyurt; Selinay Basak Erdemli Kose; Irem Iyigun; Melda Celik; Ozgur Ozyuncu; Pınar Erkekoglu; Cavit Isik Yavuz
  • Comparative in silico and in vitro evaluation of possible toxic effects of bisphenol derivatives in HepG2 cells

    Toxicology Research
    2024-07-01 | Journal article
    CONTRIBUTORS: Aylin Balci-Ozyurt; Anıl Yirun; Deniz Arca Cakır; İbrahim Ozcelik; Merve Bacanli; Gizem Ozkemahli; Suna Sabuncuoglu; Nursen Basaran; Pınar Erkekogl